1)Eaden J, Abrams KR, Mayberry JF, et al. The risk of colorectal cancer in ulcerative colitis : a meta-analysis. Gut 48 : 526-535, 2001
2)Burisch L, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 29 : 357-362, 2013
3)Rutter M, Saunders B, Wilkinson K, et al. Thirtyyear analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130 : 1030-1038, 2006
4)鈴木公孝,渡邊聡明,畑啓介,他.潰瘍性大腸炎の癌化とサーベイランスの検討─本邦報告例の検討.日本大腸肛門病会誌 56 : 62, 2003
5)Assche GV, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Prat 3 : Special situations. J Crohn Colitis 7 : 1-33, 2013
6)Marion JF, Waye JD, Present DH, et al. Chromoendoscopy targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients : a prospective endoscopic trial. Am J Gastroenterol 103 : 2342-2349, 2008
7)Watanabe T, Ajioka Y, Matsumoto T, et al. Target biopsy or step biopsy ? Optimal surveillance for ulcerative colitis : a Japanese nationwide randomized controlled trial. J Gastroenterol 46 : 11-16, 2011
8)岩男泰,長沼誠,小林拓,他.炎症性腸疾患における癌化・発育進展─UC関連大腸癌の臨床的検討.胃と腸 43 : 1925-1934, 2008
9)佐野仁,大原弘隆,中沢貴宏,他.原発性硬化性胆管炎に合併する炎症性腸疾患の臨床的特徴.胆と膵 26 : 365-372, 2005
10)Burisch L, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 29 : 357-362, 2013
11)Mowat C, Cole A, Windsor A, et al. Guidelines for the treatment of inflammatory bowel disease in adults. Gut 60 : 571-607, 2011
12)佐藤学,小川仁,柴田近,他.Infliximab投与後急激な腫瘍マーカー上昇が診断の契機となったCrohn病合併痔瘻癌の1例.日消誌 107 : 885-892, 2010